The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD
Completed
Los Angeles Biomedical Research Institute
Phase 4
2017-03-27
This trial is an investigator initiated study involving the use of the AstraZenica Aerophere
Inhaler (Glycopyrrolate/Formoterol) to determine the effect on exercise tolerance and dynamic
hyperinflation in patients with chronic obstructive lung disease.
The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD
Completed
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Phase 4
2017-03-27
This trial is an investigator initiated study involving the use of the AstraZenica Aerophere
Inhaler (Glycopyrrolate/Formoterol) to determine the effect on exercise tolerance and dynamic
hyperinflation in patients with chronic obstructive lung disease.
Effects of Bevespi on Ventilation and Gas Exchange Abnormalities in COPD Assessed by 129Xe MRI
Completed
Bastiaan Driehuys
Phase 2/Phase 3
2018-04-20
The purpose of this study is to determine whether the new inhaler, Bevespi improves lung
function. Magnetic resonance imaging (MRI) using inhaled hyperpolarized 129Xe gas, that can
provide useful images of the functioning of the lung will be used as a new measure to
determine change in function. The investigator anticipate these images will provide more
specific information about lung disease than standard lung function tests in response to
treatment.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
